Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
0(0%)
Results Posted
56%(5 trials)

Phase Distribution

Ph not_applicable
2
20%
Ph phase_1
1
10%
Ph phase_2
6
60%
Ph phase_3
1
10%

Phase Distribution

1

Early Stage

6

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
6(60.0%)
Phase 3Large-scale testing
1(10.0%)
N/ANon-phased studies
2(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(9)
Other(1)

Detailed Status

Completed9
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (10.0%)
Phase 26 (60.0%)
Phase 31 (10.0%)
N/A2 (20.0%)

Trials by Status

completed990%
unknown110%

Recent Activity

0 active trials
Showing 5 of 10
completednot_applicable

Exercise, Creatine and Coenzyme Q10 for Childhood Myositis

NCT04286178
completedphase_2

Comparing the Effects of Commercially Available Dietary Supplements on CoQ10 Concentrations

NCT06640465
completedphase_3

Coenzyme Q10 Phase III Trial in Gulf War Illness

NCT02865460
completedphase_2

Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest

NCT02934555
completedphase_2

Ubiquinol in Parkinson's Disease: Safety, Tolerability, and Effects Upon Oxidative Damage and Mitochondrial Biomarkers

NCT03061513
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT04286178Not Applicable

Exercise, Creatine and Coenzyme Q10 for Childhood Myositis

Completed
NCT06640465Phase 2

Comparing the Effects of Commercially Available Dietary Supplements on CoQ10 Concentrations

Completed
NCT02865460Phase 3

Coenzyme Q10 Phase III Trial in Gulf War Illness

Completed
NCT02934555Phase 2

Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest

Completed
NCT03061513Phase 2

Ubiquinol in Parkinson's Disease: Safety, Tolerability, and Effects Upon Oxidative Damage and Mitochondrial Biomarkers

Completed
NCT01948063Phase 2

Ubiquinol (Reduced COQ10) for Patients With Sepsis

Completed
NCT01702987Not Applicable

Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS

Completed
NCT00980694Phase 1

Bioavailability of Ubiquinol in Huntington Disease

Completed
NCT02779634Phase 2

Ubiquinol Treatment in Patients With Heart Failure and Preserved Ejection Fraction

Unknown
NCT01940627Phase 2

Influence of a Short Term Supplementation With Ubiquinol on Diverse Aspects Related to the Physical Activity

Completed

All 10 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
10